azathioprine has been researched along with Spinal Diseases in 4 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Spinal Diseases: Diseases involving the SPINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Severe pancytopenia due to azathioprine (AZA) toxicity in patients with autoimmune diseases is not uncommon." | 7.69 | Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis. ( Haas, JP; Leipold, G; Oellerich, M; Schütz, E, 1997) |
| "Severe pancytopenia due to azathioprine (AZA) toxicity in patients with autoimmune diseases is not uncommon." | 3.69 | Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis. ( Haas, JP; Leipold, G; Oellerich, M; Schütz, E, 1997) |
| "Sarcoidosis is a multi-system disorder of unknown aetiology characterised by non-caseating granulomatous inflammation with varying presentation and prognosis." | 1.36 | Osseous spinal sarcoidosis: an unusual but important entity to remember. ( Ahsan, H; Fatima, K; Haque, AS; Sheerani, M; Zubairi, AB, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zubairi, AB | 1 |
| Sheerani, M | 1 |
| Haque, AS | 1 |
| Ahsan, H | 1 |
| Fatima, K | 1 |
| Leipold, G | 1 |
| Schütz, E | 1 |
| Haas, JP | 1 |
| Oellerich, M | 1 |
| Dugowson, CE | 1 |
| Gilliland, BC | 1 |
| van Dijk, TJ | 1 |
| van Velde, JL | 1 |
1 review available for azathioprine and Spinal Diseases
| Article | Year |
|---|---|
Management of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyc | 1986 |
3 other studies available for azathioprine and Spinal Diseases
| Article | Year |
|---|---|
Osseous spinal sarcoidosis: an unusual but important entity to remember.
Topics: Adult; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Humans; Im | 2010 |
Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis.
Topics: Adolescent; Antirheumatic Agents; Arthritis; Azathioprine; Female; HLA-B27 Antigen; Homozygote; Huma | 1997 |
Treatment of pemphigus and pemphigoid with azathioprine.
Topics: Aged; Azathioprine; Candidiasis, Cutaneous; Drug Therapy, Combination; Female; Follow-Up Studies; Hu | 1973 |